Company: CMND
Filing Date: 2025-12-05
Form Type: F-1/A
Source: 0001213900-25-118772
Chunk: 211

Company: Clearmind Medicine Inc.
Filing Date: 2025-12-05
Form: F-1/A
Chunk 211
---
 Awardee is terminated for cause, any unvested Options or RSUs held by the Awardee will be immediately cancelled and forfeited to the Company for no consideration. |

131

| ● | In the event of a change of control (as defined in the Omnibus Plan), unless otherwise provided in the Omnibus Plan or an Award agreement, the Board or its delegate may deal with any or all outstanding Awards (or any portion thereof) in the manner it deems fair and reasonable in the circumstances of the change of control, including but not limited to cancelling all outstanding awards with or without payment or accelerating vesting and/or expiry of outstanding Awards and/or cause all Awards or portions thereof to become exchanged for stock awards of another corporation. |

| ● | Unless restricted by law, the Board or its delegate may alter, amend, modify, suspend or terminate the Omnibus Plan or any Award in whole or in part without notice to, or approval from, Shareholders, including, but not limited to, for the purposes of: |

| ● | making any amendments to the general vesting provisions of any Award; |

| ● | making any amendments to the general term of any Award as permitted by the Omnibus Plan; |

| ● | making any amendments to add covenants or obligations of the Company for the protection of Awardees; |

| ● | making any amendments not inconsistent with the Omnibus Plan as may be necessary or desirable with respect to matters or questions which, in the good faith opinion of the Board, it may be expedient to make, including amendments that are desirable as a result of changes in law or as a “housekeeping” matter; or |

| ● | making such changes or corrections which are required for the purpose of curing or correcting any ambiguity or defect or inconsistent provision or clerical omission or mistake or manifest error. |

| ● | Shareholder approval is required to make the following amendments to the Omnibus Plan: |

| ● | a reduction in the Option Exercise Price of a previously                                                                                 
 granted Option benefitting a Related Person or one of his/her/its Affiliates (unless done pursuant to Section 11.2 of the Omnibus Plan); |

| ● | any amendment or modification which would increase the                          
 total number of Common Shares available for issuance under the Omnibus Plan; or |

| ● | an                                                                                        
 increase to the limit on the number of Common Shares issued or issuable under the Omnibus 
 Plan to Insiders of the Company.                                                          |

132 PR